Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?

Alzheimer’s disease (AD) is a multifaceted disease that is hard to treat by single-modal treatment. AD starts with amyloid peptides, mitochondrial dysfunction, and oxidative stress and later is accompanied with chronic endoplasmic reticulum (ER) stress and autophagy dysfunction, resulting in more co...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Kelsey E., Park, Joshua J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485992/
https://www.ncbi.nlm.nih.gov/pubmed/28561773
http://dx.doi.org/10.3390/ijms18061168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485992/
https://www.ncbi.nlm.nih.gov/pubmed/28561773
http://dx.doi.org/10.3390/ijms18061168

Ejemplares similares